2012 | A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia | 허정원; 문영철 | Article |
2011 | Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype | 허정원; 문영철 | Article |
2022 | Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study | 정구용; 송승환 | Article |
2014 | Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia | 성주명 | Article |
2013 | Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category | 허정원 | Article |
2022 | Dominant predictors of early post-transplant outcomes based on the Korean Organ Transplantation Registry (KOTRY) | 정구영; 송승환 | Article |
2022 | Effect of pretransplant dialysis vintage on clinical outcomes in deceased donor kidney transplant | 정구용; 송승환 | Article |
2018 | Efficacy and safety of a new 10% intravenous immunoglobulin product in patients with primary immune thrombocytopenia (ITP) | 문영철 | Article |
2013 | Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia | 문영철 | Article |
2011 | Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia | 허정원 | Article |
2005 | High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization | 성주명 | Article |
2014 | Incidence of venous thromboembolism following major surgery in Korea: From the Health Insurance Review and Assessment Service database | 문영철 | Article |
2013 | KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement | 문영철 | Article |
2017 | Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia | 문영철 | Article |
2012 | Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia | 문영철 | Article |
2014 | Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. | 문영철 | Article |
2022 | Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea | 성주명 | Article |